We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MNK
2351
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $484K | ﹤0.01% |
180,598
+10,587
| +6% | +$31.8K |
|
2352
FRP Holdings
FRPH
$421M
| $483K | ﹤0.01% |
23,786
+1,520
| +7% | +$31.5K |
|
|
ORBC
2353
DELISTED
ORBCOMM, Inc.
ORBC
| $483K | ﹤0.01% |
125,367
+22,987
| +22% | +$68.7K |
|
|
AGNT
2354
AGNT Inc
AGNT
$734M
| $482K | ﹤0.01% |
56,496
+23,938
| +74% | +$123K |
|
2355
Costamare
CMRE
$1.77B
| $481K | ﹤0.01% |
86,511
-2,594
| -3% | -$12.6K |
|
2356
Castle Biosciences
CSTL
$979M
| $481K | ﹤0.01% |
12,764
+3,520
| +38% | +$120K |
|
2357
Capital City Bank Group
CCBG
$890M
| $480K | ﹤0.01% |
22,896
+1,930
| +9% | +$37.9K |
|
2358
Scholar Rock
SRRK
$6.44B
| $480K | ﹤0.01% |
26,371
+5,745
| +28% | +$97.9K |
|
2359
Celsius Holdings
CELH
$7.03B
| $479K | ﹤0.01% |
122,025
+28,479
| +30% | +$67.1K |
|
2360
Spyre Therapeutics
SYRE
$9.25B
| $477K | ﹤0.01% |
2,061
+543
| +36% | +$103K |
|
2361
Acacia Research
ACTG
$470M
| $476K | ﹤0.01% |
116,300
+25,850
| +29% | +$75K |
|
2362
Standard BioTools
LAB
$314M
| $476K | ﹤0.01% |
118,659
+35,494
| +43% | +$124K |
|
2363
Sterling Infrastructure
STRL
$16.7B
| $476K | ﹤0.01% |
45,438
+2,158
| +5% | +$19.9K |
|
2364
TherapeuticsMD
TXMD
$24M
| $475K | ﹤0.01% |
7,598
+1,913
| +34% | +$111K |
|
|
ACRE
2365
Ares Commercial Real Estate
ACRE
$270M
| $473K | ﹤0.01% |
51,893
-567
| -1% | -$4.42K |
|
2366
MasterCraft Boat Holdings
MCFT
$590M
| $472K | ﹤0.01% |
24,751
+685
| +3% | +$8.62K |
|
2367
SI-BONE Inc
SIBN
$834M
| $471K | ﹤0.01% |
29,562
+12,718
| +76% | +$200K |
|
|
ACBI
2368
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
| $471K | ﹤0.01% |
38,719
+1,575
| +4% | +$18.1K |
|
|
CETV
2369
DELISTED
Central European Media Enterprises Ltd
CETV
| $469K | ﹤0.01% |
132,386
+21,631
| +20% | +$80K |
|
2370
HF Foods Group
HFFG
$83.4M
| $467K | ﹤0.01% |
51,573
+31,153
| +153% | +$227K |
|
2371
Voyager Therapeutics
VYGR
$201M
| $467K | ﹤0.01% |
37,013
+3,456
| +10% | +$40.2K |
|
|
VXRT
2372
DELISTED
Vaxart
VXRT
| $466K | ﹤0.01% |
+52,675
| New | +$151K |
|
|
AD
2373
Array Digital Infrastructure
AD
$3.05B
| $465K | ﹤0.01% |
15,060
-988
| -6% | -$30.5K |
|
|
GHL
2374
DELISTED
Greenhill & Co., Inc.
GHL
| $465K | ﹤0.01% |
46,591
-7,062
| -13% | -$69.7K |
|
2375
MannKind Corp
MNKD
$1.32B
| $463K | ﹤0.01% |
264,461
+28,483
| +12% | +$39.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.